NCT05222815Completed
Glucose Monitoring Comparison in Primary Care
Comparing Fingerstick Blood Glucose Monitoring Versus Continuous Glucose Monitoring in Primary Care
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs. CGM) and compare the effectiveness through a pragmatic clinic cluster randomized design, with active glycemic management in a "usual" primary care setting, over the course of a 12 month active study period.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 360 (actual)
- First submitted
- 24 Jan 2022
- Start date
- 29 Aug 2022
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- HealthPartners Institute
- Diseases
- Type 2 diabetes
- NCT number
- NCT05222815
What you commit to
- Study type: Interventional
- Participants enrolled: 360
- From 29 Aug 2022 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unwillingness or inability to provide informed consent
- Deemed not suitable for participation in the study based on any other clinical criteria as determined by study investigator(s)
Who the study is looking for
- Age 18 to 75 (inclusive)
- Diagnosis of type 2 diabetes
- A1C 7.5% to 12% (inclusive) in the last 2 months. (If A1C is older than 2 months at the baseline visit, a point-of-care or lab A1C may be done for eligibility)
- Insulin use with or without other classes of glycemia medication use
- No significant comorbidities that could impair the ability of a primary care team to manage diabetes, including but not limited to end stage renal disease, cognitive impairment, active cancer, and pregnancy
- Established care within the HealthPartners Care Group, no plans to move within the next year, and willing to participate for the duration of the study
- Willing and able to follow procedures for collecting blinded CGM data at baseline, 6 and 12 months follow-up
- Willing to complete surveys at baseline, 3, 6, 9 and 12 months.
- Willing to use SMBG or CGM, depending on randomization, in the way that their care team recommends and/or how they feel is most useful in managing their diabetes
- Not currently using personal CGM
- Not planning to become pregnant
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| International Diabetes Center Coordinator of this site? Confirm its status | Saint Louis Park | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.